Why Nyxoah SA (NYXH) Stock Is Rising
As of 2026-08-25, Nyxoah SA (NYXH) has a next-year EPS growth estimate of 38.94%. Featured in 2 EPS revision reports, most recently on 2026-08-14.
Why NYXH Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Nyxoah SA's next-year EPS growth estimate from 35.14% to 38.94% on 2026-08-17.
- ·Current-Year Growth: Projected at 52.64%, supporting the forward estimate revision.
News Context
The primary driver is the August 17 analyst upgrade to next-year EPS growth from 35.14% to 38.94%, reflecting improved profitability expectations. That revision followed Q2 2026 results showing U.S. revenue surging 22% sequentially, a concrete fundamental catalyst. Momentum has persisted as additional events—including a $15 million EIB disbursement and an upcoming investor day—helped sustain buying interest.
Generated 2026-08-25 · news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 38.94%
- EPS growth this year
- 52.64%
- EPS next quarter (est)
- -$0.35
- Last price
- $1.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 38.94% | 52.64% | -$0.35 | $1.64 |
| 2026-08-24 | 38.94% | 52.64% | -$0.35 | $1.62 |
| 2026-08-23 | 38.94% | 52.64% | -$0.35 | $1.60 |
| 2026-08-21 | 38.94% | 52.64% | -$0.35 | $1.60 |
| 2026-08-20 | 38.94% | 52.64% | -$0.35 | $1.64 |
| 2026-08-19 | 38.94% | 52.64% | -$0.35 | $1.65 |
| 2026-08-18 | 38.94% | 52.64% | -$0.35 | $1.60 |
| 2026-08-17 | 38.94% | 52.64% | -$0.35 | $1.60 |
| 2026-08-16 | 35.14% | 51.95% | -$0.36 | $1.62 |
| 2026-08-14 | 35.68% | 49.78% | -$0.36 | $1.62 |
| 2026-08-13 | 35.68% | 49.78% | -$0.36 | $1.58 |
| 2026-08-12 | 35.68% | 49.78% | -$0.36 | $1.58 |
| 2026-08-11 | 35.68% | 49.78% | -$0.36 | $1.59 |
| 2026-08-10 | 35.68% | 49.78% | -$0.36 | $1.58 |
| 2026-08-09 | 35.68% | 49.78% | -$0.36 | $1.47 |
| 2026-08-07 | 34.79% | 50.66% | -$0.36 | $1.47 |
| 2026-08-06 | 34.80% | 50.61% | -$0.36 | $1.31 |
| 2026-08-05 | 27.76% | 50.21% | -$0.45 | $1.41 |
| 2026-08-04 | 27.76% | 50.21% | -$0.45 | $1.45 |
| 2026-08-03 | 27.76% | 50.21% | -$0.45 | $1.46 |
| 2026-08-02 | 27.76% | 50.21% | -$0.45 | $1.40 |
| 2026-07-31 | 27.76% | 50.21% | -$0.45 | $1.40 |
| 2026-07-30 | 27.76% | 50.21% | -$0.45 | $1.41 |
| 2026-07-29 | 27.76% | 50.21% | -$0.45 | $1.39 |
| 2026-07-28 | 27.76% | 50.21% | -$0.45 | $1.43 |
| 2026-07-27 | 27.76% | 50.21% | -$0.45 | $1.40 |
| 2026-07-26 | 27.76% | 50.21% | -$0.45 | $1.40 |
| 2026-07-24 | 27.76% | 50.21% | -$0.45 | $1.40 |
| 2026-07-23 | 27.76% | 50.21% | -$0.45 | $1.47 |
| 2026-07-22 | 27.76% | 50.21% | -$0.45 | $1.53 |
Reports Featuring NYXH
Recent News
- Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ...GuruFocus.com
- Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating ResultsGlobeNewswire
- Nyxoah to Host Investor Day in New York on July 8, 2026GlobeNewswire
- Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026GlobeNewswire
- Publication relating to transparency notificationsGlobeNewswire
- Nyxoah Receives $15 Million from the European Investment BankGlobeNewswire
- Why Is NYXH Stock Falling Today?Stocktwits
- Nyxoah Announces Pricing of $95 Million Underwritten Public OfferingGlobeNewswire
- Nyxoah SA (NYXH) Q1 2026 Earnings Call Highlights: Strong U.S. ...GuruFocus.com
- Nyxoah Reports First Quarter 2026 Financial and Operating ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Nyxoah SA (NYXH) stock go up recently?▾
Nyxoah SA (NYXH) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 35.14% to 38.94% on 2026-08-17. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Nyxoah SA's next-year EPS growth estimate?▾
As of 2026-08-25, Nyxoah SA (NYXH) has a next-year EPS growth estimate of 38.94%, based on analyst consensus.
When was the latest EPS estimate revision for NYXH?▾
The most recent revision occurred on 2026-08-17, when analysts adjusted the next-year EPS growth estimate from 35.14% to 38.94%.
What sector and industry does Nyxoah SA belong to?▾
Nyxoah SA operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NYXH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Nyxoah SA (NYXH) appears here because it was detected by our daily top-EPS-revision-performer screen.